Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Abbott Laboratories Clinical Trials Facts presented on Clinical Trials Search is not intended to be a substitute for qualified health advice, calls or treatment by using a real doctor. We aren't mDs. Always consult your physician about Abbott Laboratories clinical studies. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Abbott Laboratories Clinical research trials and Abbott Laboratories medical trials happen in a lot of of places across the United States. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally measure the potency of new drugs. The role of the studies / projects is to answer certain human healthcare questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies like Abbott Laboratories to detect treatments for all kinds of conditions. Abbott Laboratories Clinical Trials and other clinical trials permit volunteers to acquire health treatment choices before they are available to the general public. Many times the human subjects acquire treatment for free, and sometimes they are paid for their time. Sometimes there is a cost for a Abbott Laboratories clinical trial. Participants often get the best healthcare available for their condition. Risks are a reality, nevertheless, and can include additional or frequent physician calls, medical dangers (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.

Home > "A" Clinical Trials Sponsors > Abbott Laboratories Clinical Trials

Abbott Laboratories Clinical Trials



A Comparison of Two Types of Injected Nutritional Supplements in Patients with AIDS and Pneumocystis carinii Pneumonia (PCP)
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Multicenter Study of the Safety of Human Anti-TNF Monoclonal Antibody D2E7 in Subjects with Active Rheumatoid Arthritis
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Safety, Efficacy, and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Children With Polyarticular Juvenile Rheumatoid Arthritis
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase II Randomized Study Evaluating the Safety and Efficacy of ABT-510 in Subjects with Locally Advanced or Metastatic Soft Tissue Sarcoma
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase II Study Evaluating the Safety and Effectiveness of ABT-510 in Subjects with Refractory Lymphoma
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A phase II study of lopinavir/ritonavir in combination with saquinavir mesylate or lamivudine/zidovudine to explore metabolic toxicities in antiretroviral HIV-infected subjects
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase II Study of the Human Anti-TNF Antibody Adalimumab for the Induction of Clinical Remission in Subjects with Crohn's Disease
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase III Study Comparing Two Different Anti-HIV Drug Combinations in HIV-Positive Patients without Previous Anti-HIV Drug Therapy
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase III, Randomized Study of Atrasentan in Men with Metastatic, Hormone-Refractory Prostate Cancer
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Phase III, Randomized Study of Atrasentan in Men with Non-Metastatic, Hormone-Refractory Prostate Cancer
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Randomized, Open-Label Study of 800 mg Lopinavir/200 mg Ritonavir QD in Combination with Tenofovir and Emtricitabine vs. 400 mg Lopinavir /100 mg Ritonavir BID in Combination with Tenofovir and Emtricitabine in HIV-Infected Antiretroviral Naïve Subjects
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A simplified Kaletra® (lopinavir/ritonavir)-based therapy versus a Sustiva® (efavirenz)-based standard of care in previously non-treated HIV-infected subjects
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-378/Ritonavir Combination in HIV-Infected Patients Who Have Taken Protease Inhibitors
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-378/Ritonavir in HIV-Infected Patients
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-751 in Patients With Colorectal Cancer
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-751 in Patients With Non-Small Cell Lung Cancer
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-751 in Patients With Recurrent Breast Cancer After Taxane (Taxol or Taxotere) Therapy.
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of ABT-751 in Patients With Renal Cell Cancer
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of Ritonavir (ABT-538) When Used with Nelfinavir in HIV-Infected Patients
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of Ritonavir/Indinavir Combination in HIV-Infected Patients
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of the Safety and Efficacy of Depakote Sprinkle Capsules in the Treatment of Partial Seizures in Children
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A study of the safety and efficacy of multiple doses of ABT-089 in subjects with Alzheimer's disease
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study of Two Different Doses of ABT-378/Ritonavir in HIV-Infected Patients Who Have Taken Protease Inhibitors and Non-Nucleoside Reverse Transcriptase Inhibitors
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study to Compare Two Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Previously Received Anti-HIV Treatment
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

A Study to Examine the Use of Zemplar to Increase Serum Calcium Levels in ICU Subjects
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Adalimumab for the Induction and Maintenance of Clinical Remission in Subjects with Crohn’s Disease
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Amprenavir/Ritonavir or Saquinavir/Ritonavir in HIV-Infected Patients Following Failure with Kaletra (lopinavir/ritonavir) as Their Second Protease Inhibitor.
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Amprenavir/Ritonavir, Saquinavir/Ritonavir or Efavirenz in HIV-Infected Patients Following Failure with Kaletra (ABT-378/Ritonavir) as Their First Protease Inhibitor Based HAART
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

An Inpatient Study of the Effectiveness and Safety of Depakote ER in the Treatment of Mania/Bipolar Disorder
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Depakote ER plus an atypical antipsychotic vs. an atypical antipsychotic alone in the treatment of schizophrenia
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Depakote Monotherapy, Olanzapine Monotherapy, and Combination Therapy of Depakote Plus Olanzapine in Stable Subjects during the Maintenance Phase of Bipolar Illness
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Effectiveness of ABT-378/Ritonavir Plus Lamivudine Plus Efavirenz Plus Tenofovir DF in HIV-Infected Patients
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Evaluate the Survival Benefits of Zemplar versus Calcijex in Subjects w/ Stage V Chronic Kidney Disease on Hemodialysis
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Evaluation of Intravenous Levosimendan Efficacy in the Short Term Treatment of Decompensated Chronic Heart Failure.
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Phase I Safety Study of anti-HIV Immune Serum Globulin (Human)
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Remission in Subjects with Crohn's Disease
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Effectiveness of ABT-510 Plus Combination Chemotherapy in Subjects with Non-Small Cell Lung Cancer (NSCLC)
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Effectiveness of Zemplar Injection in decreasing iPTH levels in pediatric ESRD subjects on hemodialysis
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Efficacy of ABT-510 in Subjects with Advanced Renal Cell Carcinoma
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Efficacy of Atrasentan in Men with Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical Failure
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Efficacy of Zemplar Capsule in Reducing Serum iPTH Levels in Chronic Kidney Disease Subjects (daily dosing)
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Safety and Efficacy of Zemplar Capsule in Reducing Serum IPTH Levels in Chronic Kidney Disease Subjects (Three times weekly)
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

Study to Evaluate the Effects of Zemplar Injection and Calcijex on Intestinal Absorption of Calcium
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium avium Complex (MAC) Infection in HIV-Infected Patients
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used with or without Clofazimine in the Treatment of MAC in Patients with AIDS
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

The Safety and Effectiveness of Clarithromycin Plus Zidovudine or Dideoxyinosine in the Treatment of Mycobacterium Avium Complex (MAC) Infections in Children with AIDS
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories

The Safety and Effectiveness of Ritonavir in the Treatment of HIV-Related Kaposi's Sarcoma
Condition: abbott_laboratories_clinical_trials.html
Abbott Laboratories



Abbott Laboratories Clinical Trials
Modify your Search

Other "A" Clinical Trials Sponsors:

Aaron Diamond Aids Research Center
Abbott Laboratories
Abgenix
Academisch Medisch Centrum
Academisch Ziekenhuis Maastricht
Acambis
Achillion Pharmaceuticals
Acorda Therapeutics
Actelion
Active Biotech Research
Advanced Bionics
Advanced Peptides
Ago Ovarian Cancer Study Group
Agouron Pharmaceuticals
Aids Associated Malignancies Clinical Trials Consortium
Aji Pharma Usa
Albert Einstein Cancer Research Center
Alcon Research
Alexion Pharmaceuticals
Alfacell
Alkermes
Allergan
Allos Therapeutics
Alpha-1 Foundation
Altana Pharma
Alteon Inc.
Alza
Alzheimer's Association
American Bioscience
American College Of Radiology Imaging Network
American College Of Surgeons
American Health Foundation
American Medical Systems
American National Red Cross
Amgen
Amylin Pharmaceuticals
Anderson Clinical Research
Anges
Angiotech Pharmaceuticals
Anglo Celtic Cooperative Oncology Group
Anosys
Anthra Pharmaceuticals
Antigenics
Apex Bioscience
Apollon
Arbeitsgemeinschaft Fur Internistische Onkologie
Argus Pharmaceuticals
Ariad Pharmaceuticals
Arizona Cancer Center
Aronex Pharmaceuticals
Arqule
Arthur G. James Cancer Hospital & Richard J. Solove Research Institute
Astra Usa
Astrazeneca
Atherogenics
Atlantic Health System
Avanir Pharmaceuticals
Avant Immunotherapeutics
Avax Technologies
Aventis Pharmaceuticals
Avigen


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103